Direct-Acting Oral Anticoagulants: A Resident-Based Workshop to Improve Knowledge and Confidence
Introduction Direct-acting oral anticoagulant (DOAC) prescriptions have increased steadily since the first, dabigatran, was Food and Drug Administration-approved in 2010. They have multiple advantages over vitamin K antagonists including fixed dosing without coagulation lab monitoring, rapid onset a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Association of American Medical Colleges
2020-09-01
|
Series: | MedEdPORTAL |
Subjects: | |
Online Access: | http://www.mededportal.org/doi/10.15766/mep_2374-8265.10981 |